Levodopa/Carbidopa/Entacapon "Accord" 75+18,75+200 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levodopa/carbidopa/entacapon "accord" 75+18,75+200 mg filmovertrukne tabletter

accord healthcare b.v. - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 75+18,75+200 mg

Levodopa/Benserazid "Orifarm" 100+25 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levodopa/benserazid "orifarm" 100+25 mg tabletter

orifarm generics a/s - benserazidhydrochlorid, levodopa - tabletter - 100+25 mg

Levodopa/Carbidopa/Entacapon "Accord" 125+31,25+200 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levodopa/carbidopa/entacapon "accord" 125+31,25+200 mg filmovertrukne tabletter

accord healthcare b.v. - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 125+31,25+200 mg

Levodopa/Carbidopa/Entacapon "Accord" 150+37,5+200 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

levodopa/carbidopa/entacapon "accord" 150+37,5+200 mg filmovertrukne tabletter

accord healthcare b.v. - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 150+37,5+200 mg

Inbrija Den Europæiske Union - dansk - EMA (European Medicines Agency)

inbrija

acorda therapeutics ireland limited - levodopa - parkinsons sygdom - anti-parkinson-lægemidler - inbrija er angivet for den intermitterende behandling af episodisk motoriske fluktuationer (off episoder) hos voksne patienter med parkinsons sygdom (pd) behandles med levodopa/dopa-decarboxylase inhibitor.